In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Myocardial and Pericardial Diseases

Recommendations for further readings by the ESC Working Group on Myocardial and Pericardial Diseases

Myocardial Disease
Pericardial Disease

Cardiomyopathies 2016

Myocarditis 2016

Pericardial Disease 2016

Cardiomyopathies 2015

Myocarditis 2015

Pericardial Disease 2015

Cardiomyopathies 2013-2014

  • Lee Kh, Park  Hs, Park Ch, Kim Kh, Chung H, Kim Th, Rim Sj, Choi Ey.Extracellular Volume Imaging And Quantitative T2 Mapping For The Diagnosis Of Mitochondrial Cardiomyopathy. Circulation. 2014 Nov 11;130(20):1832-4.
  • Bogaert J, Olivotto I. Mr Imaging In Hypertrophic Cardiomyopathy: From Magnet  To Bedside. Radiology. 2014 Nov;273(2):329-48.
  • Maron Bj, Friedman Ra, Kligfield P, Et Al. American Heart Association Council On Clinical Cardiology; Advocacy Coordinating Committee; Council On Cardiovascular Disease In The Young; Council On Cardiovascular Surgery And Anesthesia; Council On Epidemiology And Prevention; Council On Functional Genomics And Translational Biology; Council On Quality Of Care And Outcomes Research, And American College  Of Cardiology. Assessment Of The 12-Lead Electrocardiogram As A Screening Test For Detection Of Cardiovascular Disease In  Healthy General Populations Of Young People (12-25 Years Of Age): A Scientific Statement From The American Heart Association And The American College Of Cardiology. J Am Coll Cardiol. 2014 Oct 7;64(14):1479-514.
  • Caselli S, Maron Ms, Urbano-Moral Ja, Pandian Ng, Maron Bj, Pelliccia A. Differentiating Left Ventricular Hypertrophy In Athletes From That In Patients  With Hypertrophic Cardiomyopathy. Am J Cardiol. 2014 Nov 1;114(9):1383-9. 
  • Cyrille Nb, Goldsmith J, Alvarez J, Maurer Ms. Prevalence And Prognostic Significance Of Low Qrs Voltage Among The Three Main  Types Of Cardiac Amyloidosis. Am J Cardiol. 2014 Oct 1;114(7):1089-93.
  • Garg J, Palaniswamy C, Lanier G. Peripartum Cardiomyopathy: Definition, Incidence, Etiopathogenesis, Diagnosis and Management. Cardiol Rev. 2014 Aug 8. [Epub ahead of print] PubMed PMID: 25111318.
  • Christiansen M, Hagen CM, Hedley PL. Mitochondrial haplogroups are associated  with hypertrophic cardiomyopathy in the Indian population. Mitochondrion. 2014 Aug 7. pii: S1567-7249(14)00101-9. doi: 10.1016/j.mito.2014.07.010. [Epub ahead of print] PubMed PMID: 25110059.
  • Allen BD, Choudhury L, Barker AJ, van Ooij P, Collins JD, Bonow RO, Carr JC,  Markl M. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2014 Aug 9. pii: jeu146. [Epub ahead of print] PubMed PMID: 25108915.
  • Seki A, Perens G, Fishbein MC. Posterolateral hypertrophic cardiomyopathy: a  rare, but clinically significant variant of hypertrophic cardiomyopathy. Cardiovasc Pathol. 2014 Jul 15. pii: S1054-8807(14)00077-5. doi: 10.1016/j.carpath.2014.07.002. [Epub ahead of print] PubMed PMID: 25108499.
  • Amaki M, Savino J, Ain DL, Sanz J, Pedrizzetti G, Kulkarni H, Narula J, Sengupta PP. Diagnostic Concordance of Echocardiography and CMR-Based Tissue Tracking for Differentiating Constrictive Pericarditis from Restrictive Cardiomyopathy. Circ Cardiovasc Imaging. 2014 Aug 8. pii: CIRCIMAGING.114.002103.
    [Epub ahead of print] PubMed PMID: 25107553.
  • Paterick TE, Tajik AJ. Left Ventricular Noncompaction Cardiomyopathy: Lessons
    from the Past to Explain a Diagnostic Conundrum. J Am Soc Echocardiogr. 2014 Aug
    5. pii: S0894-7317(14)00477-5. doi: 10.1016/j.echo.2014.06.015. [Epub ahead of print] PubMed PMID: 25107378.
  • Zhang HJ, Wang H, Sun T, Lu MJ, Xu N, Wu WC, Sun X, Wang WG, Lin QW. Assessment of left ventricular twist mechanics by speckle tracking echocardiography reveals association between LV twist and myocardial fibrosis in  patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2014 Aug 9. [Epub ahead of print] PubMed PMID: 25106760.
  • Grigoratos C, Bratis K, Henningsson M, Mahmoud I, Nagel E. Chemotherapy-related cardiomyopathy in acute myeloid leukaemia assessed by cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2014 Aug 7. pii: jeu150. [Epub ahead of print] PubMed PMID: 25104811.
  • Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL. Extent of Coronary and Myocardial Disease and Benefit From Surgical Revascularization in LV Dysfunction. J Am Coll Cardiol. 2014 Aug 12;64(6):553-561. doi: 10.1016/j.jacc.2014.04.064. PubMed PMID: 25104523.
  • Komatsu Y, Jadidi A, Sacher F, Denis A, Daly M, Derval N, Shah A, Lehrmann H, Park CI, Weber R, Arentz T, Pache G, Sermesant M, Ayache N, Relan J, Montaudon M, Laurent F, Hocini M, Haïssaguerre M, Jaïs P, Cochet H. Relationship Between MDCT-Imaged Myocardial Fat and Ventricular Tachycardia Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Heart Assoc. 2014 Aug 7;3(4). pii: e000935. PubMed PMID: 25103203.
  • Tanaka H, Kamiya C, Katsuragi S, Tanaka K, Miyoshi T, Tsuritani M, Yoshida M, Iwanaga N, Neki R, Yoshimatsu J, Ikeda T. Cardiovascular Events in Pregnancy With Hypertrophic Cardiomyopathy. Circ J. 2014 Aug 6. [Epub ahead of print] PubMed; PMID: 25099604.
  • Sharkey SW, Maron BJ. Epidemiology and Clinical Profile of Takotsubo Cardiomyopathy. Circ J. 2014 Aug 5. [Epub ahead of print] PubMed PMID: 25099475.
  • Groarke JD, Choueiri TK, Slosky D, Cheng S, Moslehi J. Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway. Curr Treat Options Cardiovasc Med. 2014 Sep;16(9):335. doi: 10.1007/s11936-014-0335-0. PubMed PMID:  25099086.
  • Cavigelli-Brunner A, Schweiger M, Knirsch W, Stiasny B, Klingel K, Kretschmar O, Hübler M. VAD as Bridge to Recovery in Anthracycline-Induced Cardiomyopathy and HHV6 Myocarditis. Pediatrics. 2014 Aug 4. pii: peds.2013-2272. [Epub ahead of print] PubMed PMID: 25092940.
  • Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C,  Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value  of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094. PubMed PMID: 25092278.
  • Li J, Maguy A, Elber Duverger J, Vigneault P, Comtois P, Shi Y, Tardif JC, Thomas D, Nattel S. Induced KCNQ1 Autoimmunity Accelerates Cardiac Repolarization in Rabbits: Potential Significance in Arrhythmogenesis and Antiarrhythmic Therapy. Heart Rhythm. 2014 Jul 31. pii: S1547-5271(14)00851-0. doi: 10.1016/j.hrthm.2014.07.040. [Epub ahead of print] PubMed PMID: 25087487.
  • Groeneweg JA, Ummels A, Mulder M, Bikker H, van der Smagt JJ, van Mil AM, Homfray T, Post JG, Elvan A, van der Heijden JF, Houweling AC, Jongbloed JD, Wilde AA, van Tintelen JP, Hauer RN, Dooijes D. Functional Assessment of Potential Splice Site Variants in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Heart Rhythm. 2014 Jul 31. pii: S1547-5271(14)00852-2.  doi: 10.1016/j.hrthm.2014.07.041. [Epub ahead of print] PubMed PMID: 25087486.
  • Al-Khatib SM, Hellkamp AS, Fonarow GC, et al. Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. JAMA. 2014 Jun 4;311(21):2209-15. 
  • Kobayashi T, Dhillon A, Popovic Z, et al. Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy. Am  J Cardiol. 2014 Jun 1;113(11):1879-85.
  • Li X, Luo R, Jiang R, et al. The prognostic use of serum concentrations of cardiac troponin-I, CK-MB and myoglobin in patients with  idiopathic dilated cardiomyopathy. Heart Lung. 2014 May-Jun;43(3):219-24.
  • Saguner AM, Ganahl S, Baldinger SH, et al. Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 2014 May 15;113(10):1728-34.
  • Coats C, Mills K, Elliott P.  Novel Insights into the Pathophysiology of Hypertrophic Cardiomyopathy Using Label free Quantitative Proteomics. Heart. 2014 Jun;100(Suppl 3):A89-A90.
  • Captur G, Mohun TJ, Finocchiaro G, Wilson R, Levine J, Conner L, Lopes L, Patel V, Sado DM, Li C, Bassett P, Herrey A, Tome Esteban M, McKenna WJ, Seidman  C, Muthurangu V, Bluemke DA, Ho CY, Elliott PM, Moon JC. Advanced Assessment  of Cardiac Morphology and Prediction of Gene Carriage by CMR in Hypertrophic Cardiomyopathy - The HCMNET/UCL Collaboration. Heart. 2014 Jun;100(Suppl 3):A72-A73.
  • Ferreira V, Marcelino M, Piechnik S, Marini C, Karamitsos T, Francis J, Ranjit Arnold J, Mihai R, Thomas J, Herincs M, Korbonits M, Hassan-Smith Z, Arlt W, Karavitaki N, Grossman A, Wass J, Neubauer S. Cardiac Abnormalities are Common in Patients Diagnosed with Phaeochromocytoma as Detected by Cardiovascular Magnetic Resonance Imaging. Heart. 2014 Jun;100(Suppl 3):A70.
  • Pantazis A, Hong Cheang M, Mullen M, Elliott P, Mckenna W, Kumar Aggarwal S, Teresa TomeEsteban M, Reinthaler M, Delahunty N. Percutaneous Mitral Repair in Hypertrophic Cardiomyopathy. Heart. 2014 Jun;100(Suppl 3):A54-A55.
  • Khouw N, Wasim M, Uppal H, Chandran S, Potluri R. Predictors of Mortality in Patients with Hypertrophic Cardiomyopathy - A Hospital Admissions Study: 2000-2013. Heart. 2014 Jun;100(Suppl 3):A52.
  • Malhotra A, Sheikh N, Dhutia H, Siva A, Millar L, Merghani A, Narain R, Dores  H, Sharma S, Papadakis M. Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy in Athletes: Proposed Echocardiographic Protocol. Heart. 2014 Jun;100(Suppl 3):A52.
  • Sheikh N, Papadakis M, Malhotra A, Millar L, Dhutia H, Merghani A, Narain R, Wilson M, McKenna W, Sharma S. The Electrocardiographic Phenotype in Athletes with Hypertrophic Cardiomyopathy: Implications for Pre-Participation Cardiovascular Evaluation Using Electrocardiography. Heart. 2014 Jun;100(Suppl 3):A51.
  • Coats C, Rantell K, Bartnik O, Patel A, Mist B, McKenna W, Elliott P. Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy. Heart. 2014 Jun;100(Suppl 3):A50-A51. doi: 10.1136/heartjnl-2014-306118.88.
  • Theis JL, Zimmermann MT, Larsen BT, Rybakova IN, Long PA, Evans JM, Middha S, De Andrade M, Moss RL, Wieben ED, Michels VV, Olson TM. TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy.Hum Mol Genet. 2014 Jun 11. pii: ddu297.
  • van Rijsingen IA, van der Zwaag PA, Groeneweg JA, Nannenberg EA, Jongbloed JD, Zwinderman AH, Pinto YM, Lekanne Dit Deprez RH, Post JG, Tan HL, de Boer RA, Hauer RN, Christiaans I, van den Berg MP, van Tintelen JP, Wilde AA. Outcome in Phospholamban R14del Carriers: Results of a Large Multicentre Cohort Study. Circ Cardiovasc Genet. 2014 Jun 8. pii: CIRCGENETICS.113.000374.
  • Chen X, Zhao T, Lu M, Yin G, Xiangli W, Jiang S, Prasad S, Zhao S. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2014 Apr 11. [Epub ahead of print].
  • Millat G, Chanavat V, Rousson R. Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of  genetic variations in cardiomyopathies. Clin Chim Acta. 2014 Apr 7. pii: S0009-8981(14)00152-1. doi: 10.1016/j.cca.2014.03.032. [Epub ahead of print].
  •  Lassner D, Kühl U, Rohde M, Siegismund CS, Schultheiss HP. CCR5del32 polymorphism is a protective factor in non-ischemic cardiomyopathy. Int J Cardiol. 2014 Mar 21. pii: S0167-5273(14)00559-2. doi:10.1016/j.ijcard.2014.03.123. [Epub ahead of print].
  • Wong TC. Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial  Expansion in Hypertrophic Cardiomyopathy. Curr Cardiovasc Imaging Rep. 2014;7:9267.
  • Andò G, Boretti I, Tripodi R. Stress cardiomyopathies beyond Takotsubo: does a common catecholaminergic pathophysiology fit all? Expert Rev Cardiovasc Ther. 2014 Apr 10. [Epub ahead of print].
  • Nishii T, Kono AK, Shigeru M, Takamine S, Fujiwara S, Kyotani K, Aoyama N, Sugimura K. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging. 2014 Apr 9. [Epub ahead of print].
  • Edwards NC, Teoh JK, Steeds RP. Hypertrophic cardiomyopathy and Anderson-Fabry disease: unravelling septal hypertrophy with T1-mapping CMR. Eur Heart J. 2014 Apr 8. [Epub ahead of print].
  • Marsiglia JD, Pereira AC. Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease? Arq Bras Cardiol. 2014 Mar;102(3):295-304.
  • Dittmer TA, Sahni N, Kubben N, Hill DE, Vidal M, Burgess RC, Roukos V, Misteli T. Systematic identification of pathological lamin A interactors. Mol Biol Cell. 2014 Mar 12. [Epub ahead of print] PubMed PMID: 24623722.
  • Smith WA, Ness KK, Joshi V, Hudson MM, Robison LL, Green DM. Exercise training in childhood cancer survivors with subclinical cardiomyopathy who were treated with anthracyclines. Pediatr Blood Cancer. 2013 Nov 6. doi: 10.1002/pbc.24850.[Epub ahead of print] PubMed PMID: 24623535.
  • Shimada YJ, Passeri JJ, Baggish AL, O'Callaghan C, Lowry PA, Yannekis G, Abbara S, Ghoshhajra BB, Rothman RD, Ho CY, Januzzi JL, Seidman CE, Fifer MA. Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy. JACC Heart Fail. 2013 Dec;1(6):480-7. doi: 10.1016/j.jchf.2013.09.001. Epub 2013 Oct 24. PubMed PMID: 24621999.
  • Fujita T, Fujino N, Anan R, Tei C, Kubo T, Doi Y, Kinugawa S, Tsutsui H, Kobayashi S, Yano M, Asakura M, Kitakaze M, Komuro I, Konno T, Hayashi K, Kawashiri MA, Ino H, Yamagishi M. Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: results from multicenter registration in Japan. JACC Heart Fail. 2013 Dec;1(6):459-66. doi: 10.1016/j.jchf.2013.08.007. Epub 2013 Oct 24. PubMed PMID: 24621997.
  • Gray B, Ingles J, Medi C, Semsarian C. Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy. JACC Heart Fail. 2013 Apr;1(2):149-55. doi: 10.1016/j.jchf.2013.01.004. Epub 2013 Apr 1. PubMed PMID: 24621839.
  • Hirashiki A, Kondo T, Adachi S, Nakano Y, Shimazu S, Shimizu S, Morimoto R, Okumura T, Murohara T. Prognostic Value of Pulmonary Hypertension in Ambulatory Patients With Non-Ischemic Dilated Cardiomyopathy. Circ J. 2014 Mar 13. [Epub ahead of print] PubMed PMID: 24621657.
  • Goemans N, Buyse G. Current treatment and management of dystrophinopathies. Curr Treat
  • Ahtarovski KA, Iversen KK, Christensen TE, et al. Takotsubo cardiomyopathy, a two-stage recovery of left ventricular systolic and diastolic function as determined by cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2014 Feb 12. [Epub ahead of print]
  • Kwong RY, Jerosch-Herold M. CMR and Amyloid Cardiomyopathy: Are We Getting Closer to the Biology? JACC Cardiovasc Imaging. 2014 Feb;7(2):166-8.
  • Hen Y, Iguchi N, Utanohara Y, et al. Prognostic Value of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Japanese Hypertrophic Cardiomyopathy Patients. Circ J. 2014 Feb 13. [Epub ahead of print]
  • Xu HY, Yang ZG, Sun JY, et al. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: Assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance. Eur J Radiol. 2014 Jan 16. [Epub ahead of print]
  • Zhang C, Chen B, Guo et al. Microtubule-Mediated Defects in Junctophilin-2 Trafficking Contribute to Myocyte  T-Tubule Remodeling and Ca2+ Handling Dysfunction in Heart Failure. Circulation.  2014 Feb 11. [Epub ahead of print]
  • Saguner AM, Vecchiati A, Baldinger SH, et al. Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circ Cardiovasc Imaging. 2014 Feb 10.[Epub ahead of print]
  • Brothers MB, Oster ME, Ehrlich A, et al. Novel Electrocardiographic Screening Criterion for Hypertrophic Cardiomyopathy in Children. Am J Cardiol. 2014 Jan 16. [Epub ahead of print]
  • Sadjadieh G, Jabbari R, Risgaard B, et al. Nationwide (Denmark) Study of Symptoms Preceding Sudden Death due to Arrhythmogenic Right Ventricular Cardiomyopathy. Am J Cardiol. 2014 Jan 16. [Epub ahead of print]
  • Cramer G, Bakker J, Gommans F, et al. Relation of Highly Sensitive Cardiac Troponin T in Hypertrophic Cardiomyopathy to Left Ventricular Mass and Cardiovascular Risk. Am J Cardiol. 2014 Jan 16. [Epub ahead of print] 
    • Geske JB, Konecny T, Ommen SR, et al. Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy.  Eur Heart J. 2013 Dec 13. [Epub ahead of print]
    • Khawaja MZ, Cafferkey C, Rajani R, Redwood S, Cunningham D. Cardiac complications and manifestations of chemotherapy for cancer. Heart. 2013 Dec 10. [Epub ahead of print]
    • Azarbal F, Singh M, Finocchiaro G, et al. Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. Heart. 2013 Dec 10. [Epub ahead of print]
    • Olde Nordkamp LR, Warnaars JL, Kooiman KM, et al. Which Patients are Not Suitable for a Subcutaneous ICD: Incidence and Predictors of Failed QRS-T-Wave Morphology Screening. J Cardiovasc Electrophysiol. 2013 Dec 9.  [Epub ahead of print]
    • Azarbal F, Singh M, Finocchiaro G, et al. Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. Heart. 2013 Dec 10. [Epub ahead of print]
    • Ozawa K, Funabashi N, Takaoka H, et al. Various morphological-types of all and fragmented ventricular premature beats on a 12-lead Holter-ECG had positive-relationship with occurrence of LV fibrosis on CT in HCM subjects. Int J Cardiol. 2013 Dec 3. [Epub ahead of print]
    • Martinelli M, Rassi A Jr, Marin-Neto JA, et al. Chronic use of Amiodarone against Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: Rationale and design of a randomized clinical trial.  Am Heart J. 2013 Dec;166(6):976-982.
    • Peled Y, Gramlich M, Yoskovitz G, et al. Titin Mutation in Familial Restrictive Cardiomyopathy. Int J Cardiol. 2013 Nov 25. pii: S0167-5273(13)02055-X. doi: 10.1016/j.ijcard.2013.11.037.
    • Yalcinkaya E, Bugan B, Celik M, et al. Cardiomyopathies: The Value of Cardiac Magnetic Resonance Imaging. Med Princ Pract. 2013 Nov 21. [Epub  ahead of print].
    • Pettersen MD. Cardiomyopathies encountered commonly in the teenage years and their presentation. Pediatr Clin North Am. 2014 Feb;61(1):173-86. 
    • Brodehl A, Dieding M, Klauke B, et al. The Novel Desmin Mutant p.A120D Impairs Filament Formation, Prevents Intercalated Disk Localization and Causes Sudden Cardiac Death. Circ Cardiovasc Genet. 2013 Nov 7. [Epub ahead of print].
    • Coppini R, Rajamani S, Olivotto I, et al. Paradoxical
      Prolongation of QT Interval During Exercise in Patients with Hypertrophic Cardiomyopathy. Heart Rhythm. 2013 Nov;10(11):1752. Epub 2013 Oct 24.
    • D'Argenio V, Frisso G, Precone V, et al. DNA Sequence Capture and Next-Generation Sequencing for the Molecular Diagnosis of Genetic Cardiomyopathies. J Mol Diagn.  2013 Oct 31. pii: S1525 1578(13)00212-2.
    • Lipshultz SE, Cochran TR, Briston DA, et al. Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies. Future Cardiol. 2013 Nov;9(6):817-48.
    • Pieroni M, Camporeale A, Della Bona R, et al.. Progression of Fabry cardiomyopathy despite enzyme replacement therapy. Circulation. 2013 Oct 8;128(15):1687-8. doi:
      10.1161/CIRCULATIONAHA.113.002799. PubMed PMID: 24100483.
    • Marsiglia JD, Credidio FL, de Oliveira TG, et al. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy. Am Heart J. 2013 Oct;166(4):775-82. doi: 10.1016/j.ahj.2013.07.029. Epub 2013 Sep 18. PubMed PMID: 24093860.
    • Canepa M, Sorensen LL, Pozios I, et al. Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013 Oct 15;112(8):1182-9. doi: 10.1016/j.amjcard.2013.05.070. PubMed PMID: 24079444.
    • Litwin SE. Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy? Diabetes. 2013 Oct;62(10):3329-30. doi: 10.2337/db13-0683. PubMed PMID: 24065790; PubMed Central PMCID: PMC3781487.
    • Saguner AM, Duru F, Brunckhorst CB. Arrhythmogenic right ventricular cardiomyopathy: a challenging disease of the intercalated disc. Circulation. 2013 Sep 17;128(12):1381-6. doi: 10.1161/CIRCULATIONAHA.112.001009. PubMed PMID: 24043146.
    • Alexander PM, Daubeney PE, Nugent AW, et al. National Australian Childhood Cardiomyopathy Study. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation. 2013 Oct 29;128(18):2039-46. doi: 10.1161/CIRCULATIONAHA.113.002767. Epub 2013 Sep 13. PubMed PMID: 24036608.
    • Coppini R, Rajamani S, Olivotto I, et al. Paradoxical Prolongation of QT Interval During Exercise in Patients with Hypertrophic Cardiomyopathy. Heart Rhythm. 2013 Nov;10(11):1752. Epub 2013 Oct 24.
    • Roncarati R, Anselmi CV, Losi MA, et al.  Circulating miR-29a, Among Other Upregulated microRNAs, is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2013 Oct 10. doi:pii: S0735-1097(13)05589-7. 10.1016/j.jacc.2013.09.041. [Epub ahead of print
    • Finocchiaro G, Knowles JW, Pavlovic A, et al. Prevalence and Clinical Correlates of Right
      Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2013 Oct 4. pii: S0002-9149(13)01981-4. doi: 10.1016/j.amjcard.2013.09.045. [Epub ahead of print]


Myocarditis 2013-2014

  • Gerfaud-Valentin M, Sève P, Iwaz J, Et Al.Myocarditis In Adult-Onset Still Disease . Medicine (Baltimore). 2014 Oct;93(17):280-9.
  • Anderson  Br, Silver Es, Richmond Me, Liberman L. Usefulness Of Arrhythmias As  Predictors Of Death And Resource Utilization In Children With Myocarditis. Am J Cardiol. 2014 Nov 1;114(9):1400-5.
  • Von Olshausen G, Hyafil F, Langwieser N, Laugwitz Kl, Schwaiger M, Ibrahim T.  Detection Of Acute Inflammatory Myocarditis In Epstein Barr Virus Infection Using Hybrid  18f-Fluoro-Deoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging. Circulation. 2014 Sep 9;130(11):925-6.
  • Cavigelli-Brunner A, Schweiger M, Knirsch W, Et Al. Vad As Bridge To Recovery  In Anthracycline-Induced Cardiomyopathy And Hhv6 Myocarditis. Pediatrics. 2014 Sep;134(3):E894-9.
  • Luetkens Ja, Doerner J, Thomas Dk, Et Al. Acute Myocarditis: Multiparametric Cardiac Mr Imaging. Radiology. 2014 Nov;273(2):383-92.
  • Anderson BR, Silver ES, Richmond ME, Liberman L. Usefulness of arrhythmias as  predictors of death and resource utilization in children with myocarditis. Am J
  • Cardiol. 2014 Nov 1;114(9):1400-5. doi: 10.1016/j.amjcard.2014.07.074. Epub 2014
    Aug 12. PubMed PMID: 25200339.
  • von Olshausen G, Hyafil F, Langwieser N, Laugwitz KL, Schwaiger M, Ibrahim T. Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging. Circulation. 2014 Sep 9;130(11):925-6. doi: 10.1161/CIRCULATIONAHA.114.011000. PubMed PMID: 25199667.
  • Luetkens JA, Doerner J, Thomas DK, Dabir D, Gieseke J, Sprinkart AM, Fimmers R, Stehning C, Homsi R, Schwab JO, Schild H, Naehle CP. Acute Myocarditis: Multiparametric Cardiac MR Imaging. Radiology. 2014 Nov;273(2):383-92. doi: 10.1148/radiol.14132540. Epub 2014 Jun 6. PubMed PMID: 24910904.
  • Cavigelli-Brunner A, Schweiger M, Knirsch W, Stiasny B, Klingel K, Kretschmar  O, Hübler M. VAD as bridge to recovery in anthracycline-induced cardiomyopathy
    and HHV6 myocarditis. Pediatrics. 2014 Sep;134(3):e894-9. doi: 10.1542/peds.2013-2272. Epub 2014 Aug 4. PubMed PMID: 25092940
  • Florian A, Ludwig A, Ong P, et al. Cause of cardiac disease in a female carrier of Duchenne muscular dystrophy: myocarditis versus genetic cardiomyopathy without skeletal myopathy? Circulation. 2014 May 6;129(18):e482-4.
  • Sujino Y, Kimura F, Tanno J, et al. Cardiac magnetic resonance imaging in giant cell myocarditis: intriguing associations with clinical and pathological features. Circulation. 2014 Apr 29;129(17):e467-9
  • de Miguel V, Arias A, Paissan A, et al. Catecholamine-induced myocarditis in pheochromocytoma. Circulation. 2014 Mar 25;129(12):1348-9.
  • Barnado A, Kamen DL. Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematous and myositis. Am J Med Sci. 2014 Mar;347(3):256-7.
  • Luetkens JA, Doerner J, Thomas DK, Dabir D, Gieseke J, Sprinkart AM, Fimmers R, Stehning C, Homsi R, Schwab JO, Schild H, Naehle CP. Acute Myocarditis: Multiparametric Cardiac MR Imaging. Radiology. 2014 Jun 6:132540.
  • Wang D, Chen Y, Jiang J, Zhou A, Pan L, Chen Q, Yan Q, Chu M, Chen C. Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. Gene. 2014 Jun  3. pii: S0378-1119(14)00667-2. 
  • Jeserich M, Olschewski M, Kimmel S, Bode C, Geibel A. Acute results and long-term follow-up of patients with accompanying myocarditis after viral respiratory or gastrointestinal tract infection. Int J Cardiol. 2014 Apr 29. pii: S0167-5273(14)00878-X.
  • Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J. 2014 May 23;78(6):1302-10.
    Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ. MicroRNA‑21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep. 2014 Jul;10(1):161-8.
  • Shim SH, Kim DS, Cho WJ, Nam JH. Coxsackievirus B3 regulates T cell infiltration into the heart by LFA-1 activation via the cAMP/Rap1 axis.J Gen Virol. 2014 Jun 11. pii: vir.0.065755-0. doi: 10.1099/vir.0.065755-0
    Su Z, Yin J, Wang T, Sun Y, Ni P, Ma R, Zhu H, Zheng D, Shen H, Xu W, Xu H. Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1. J Cell Mol Med. 2014 Jun 9. doi: 10.1111/jcmm.12324.
  • Ferreira LR, Frade AF, Santos RH, Teixeira PC, Baron MA, Navarro IC, Benvenuti LA, Fiorelli AI, Bocchi EA, Stolf NA, Chevillard C, Kalil J, Cunha-Neto E. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy. Int J Cardiol. 2014 May 17. pii: S0167-5273(14)01002-X. doi: 10.1016/j.ijcard.2014.05.019.
  • Perazzolo Marra M, Thiene G, Rizzo S, De Lazzari M, Carturan E, Tona F, Caforio AL, Cacciavillani L, Marcolongo R, Tarantini G, Corbetti F, Iliceto S, Basso C. Cardiac Magnetic Resonance Features of Biopsy-Proven Endomyocardial Diseases. JACC Cardiovasc Imaging. 2014 Mar;7(3):309-12.
  • Toscano G, Tartaro P, Fedrigo M, Angelini A, Marcolongo R. Rituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach. Transpl Int. 2014 Jan 20. doi: 10.1111/tri.12270.
  • Yacoub S, Wertheim H, Simmons CP, Screaton G, Wills B. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev Cardiol. 2014 Apr 8. doi: 10.1038/nrcardio.2014.40
  • Groh M, Masciocco G, Kirchner E, Kristen A, Pellegrini C, Varnous S, Bortman G, Rosenberg M, Brucato A, Waterworth P, Bonacina E, Facchetti F, Calabrese L, Gregorini G, Scali JJ, Starling R, Frigerio M, D'Armini AM, Guillevin L. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). J Heart Lung Transplant. 2014 Feb 24. pii: S1053-2498(14)01001-8. doi: 10.1016/j.healun.2014.02.023. [Epub ahead of print]
  • Manautou L, Jerjes-Sanchez C, Meraz M, Perez-Garcia LF, Diaz-Cid A, Peña-Almaguer ED, Avila C, Sanchez L. Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus. Lupus. 2014 Apr 4. [Epub ahead of print]
  • Esper L, Utsch L, Soriani FM, Brant F, Esteves Arantes RM, Campos CF, Pinho V, Souza DG, Teixeira MM, Tanowitz HB, Vieira LQ, Machado FS. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection. Microbes Infect. 2014 Apr 1. pii: S1286-4579(14)00036-7. doi: 10.1016/j.micinf.2014.03.007. [Epub ahead of print]
  • Wang X, Li M, Xie Y, Yu Y, Liu G, Yu Y, Yang X, Zou Y, Ge J, Chen R. The Frequency of Invariant Natural Killer T Cells Correlates with the Severity of Myocarditis. Viral Immunol. 2014 Apr 4. [Epub ahead of print]
  • Bissel SJ, Winkler CC, Deltondo J, Wang G, Williams K, Wiley CA. Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins. Neuropathology. 2014 Apr 7. doi: 10.1111/neup.12121. [Epub ahead of print]
  • Jenke A, Holzhauser L, Löbel M, Savvatis K, Wilk S, Weithäuser A, Pinkert S, Tschöpe C, Klingel K, Poller W, Scheibenbogen C, Schultheiss HP, Skurk C. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses. Basic Res Cardiol. 2014 May;109(3):408. doi: 10.1007/s00395-014-0408-y. Epub 2014 Apr 2.
  • Esposito S, Rahamat-Langendoen J, Ascolese B, Senatore L, Castellazzi L, Niesters HG. Pediatric parechovirus infections. J Clin Virol. 2014 Mar 13. pii: S1386-6532(14)00095-X. doi: 10.1016/j.jcv.2014.03.003. [Epub ahead of print]
  • Benvenuti LA, Roggério A, Nishiya AS, Campos SV, Fiorelli AI, Levi JE. Trypanosoma cruzi persistence in the native heart is associated with high-grade myocarditis, but not with Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant. 2014 Feb 4. pii: S1053-2498(14)00951-6. doi: 10.1016/j.healun.2014.01.920. [Epub ahead of print]
  • Yang WI, Lee D, Lee DL, Hong SY, Lee SH, Kang SM, Choi DH, Jang Y, Kim SH, Park S. Blocking the Receptor for Advanced Glycation End Product Activation Attenuates Autoimmune Myocarditis. Circ J. 2014 Mar 6. [Epub ahead of print] PubMed PMID: 24599045.
  • Munshi TA, Volochniouk D, Hassan T, Mazhar N. Clozapine-induced myocarditis: is mandatory monitoring warranted for its early recognition? Case Rep Psychiatry. 2014;2014:513108. doi: 10.1155/2014/513108. Epub 2014 Jan 23. PubMed PMID: 24587933; PubMed Central PMCID: PMC3920926.
  • Nensa F, Poeppel TD, Krings P, Schlosser T. Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging. Eur Heart J. 2014 Feb 26. [Epub ahead of print] PubMed PMID: 24578391.
  • Zhang Y, Jiang L, Zhang M, Lv K. Galectin-9 Induced Myeloid Suppressor Cells Expand Regulatory T Cells in an IL-10-Dependent Manner in CVB3-Induced Acute Myocarditis. Int J Mol Sci. 2014 Feb 25;15(3):3356-72. doi: 10.3390/ijms15033356. PubMed PMID: 24573249.
  • Francone M, Chimenti C, Galea N, Scopelliti F, Verardo R, Galea R, Carbone I, Catalano C, Fedele F, Frus